<Disease><Name>2-HYDROXYGLUTARIC ACIDURIA (D) TYPE I</Name><Synonym>D-2-HYDROXYGLUTARIC ACIDURIA 1; D2HGA1</Synonym><OMIM><Number>600721</Number><URL>http://omim.org/entry/600721</URL></OMIM><Orphanet><Number>79315</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=79315</URL></Orphanet><Protein><Number>D-2-hydroxyglutarate dehydrogenase, mitochondrial</Number><URL>http://www.uniprot.org/uniprot/Q8N465</URL></Protein><ExPASy><Number>1.1.99.39</Number><URL>http://enzyme.expasy.org/EC/1.1.99.39</URL></ExPASy><Gene>2q37.3</Gene><ICD>E72.8</ICD><Summary>rare (&lt;1:1000000);autosomal recessive ;mutation in the D-2-hydroxyglutarate dehydrogenase gene ;biochemical variant of 2-hydroxyglutaric aciduria: ;- L-2-hydroxyglutaric aciduria ;- D-2-hydroxyglutaric aciduria ;- combined D-2- and L-2-hydroxyglutaric aciduria</Summary><Symptoms><symtomp><id>2233</id><symptom>alopecia</symptom><category>SKIN | SKIN</category></symtomp><symtomp><id>2347</id><symptom>anemia</symptom><category>IMMUNE OR HEMATOLOGIC SYSTEM | LABORATORY FINDINGS</category></symtomp><symtomp><id>2241</id><symptom>athetosis</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>2130</id><symptom>bleeding tendencies, hemorrhages / bleeding tendencies, hemorrhage</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2211</id><symptom>blindness, visual loss, visual impairment</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2104</id><symptom>cardiomyopathy</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>3204</id><symptom>corpus callosum, agenesis/hypoplasia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3819</id><symptom>developmental delay</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2227</id><symptom>dysmorphism / dysmorphic features</symptom><category>HEAD</category></symtomp><symtomp><id>2160</id><symptom>EEG abnormalities [-]</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>3709</id><symptom>epilepsy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2169</id><symptom>hyperpigmentation</symptom><category>SKIN</category></symtomp><symtomp><id>1897</id><symptom>hypotonia</symptom><category>MUSCLES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2251</id><symptom>infantile spasms</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1951</id><symptom>irritability</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1887</id><symptom>macrocephaly (large calvaria, &gt;2 SD for age)</symptom><category>HEAD</category></symtomp><symtomp><id>2424</id><symptom>mental retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3363</id><symptom>metaphyseal dysplasia</symptom><category>SKELETAL DEFECT</category></symtomp><symtomp><id>2213</id><symptom>MRI, brain, abnormalities [-]</symptom><category>LABORATORY FINDINGS | NERVOUS SYSTEM</category></symtomp><symtomp><id>2426</id><symptom>MRI, brain, white matter abnormalities [-]</symptom><category>LABORATORY FINDINGS | NERVOUS SYSTEM</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2504</id><symptom>onset, neonatal / neonatal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2266</id><symptom>Organic acid, spinal fluid</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2075</id><symptom>Organic acids, plasma</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2089</id><symptom>Organic acids, urine</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>1939</id><symptom>peripheral neuropathy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1943</id><symptom>seizures</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>1874</id><symptom>speech development, delayed, abnormal</symptom><category>GENERAL TOPICS | NERVOUS SYSTEM</category></symtomp><symtomp><id>1980</id><symptom>vomiting</symptom><category>GASTROINTESTINAL SYSTEM | GENERAL TOPICS</category></symtomp><symtomp><id>3902</id><symptom>white matter changes, abnormalities</symptom><category>NERVOUS SYSTEM</category></symtomp></Symptoms><Metabolites><metabolite><id>1857</id><name>4-Aminobutyric acid</name><specimen>urine</specimen><value /><min>2.70</min><max>3.30</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1706</id><name>Succinic acid</name><specimen>urine</specimen><value>increased</value><min>9.00</min><max>360.00</max><unit>mmol/mol creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1789</id><name>4-Aminobutyric acid</name><specimen>urine</specimen><value>increased</value><min>17.00</min><max>20.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>1817</id><name>Succinic acid</name><specimen>urine</specimen><value>increased</value><min>9.00</min><max>360.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>2061</id><name>2-Oxoglutaric acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>50.00</max><unit>mmol/mol creatinine</unit><age>ALL</age><method>GCMS</method><comment /></metabolite><metabolite><id>2100</id><name>2-Oxoglutaric acid</name><specimen>urine</specimen><value>increased</value><min>60.00</min><max>120.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method>GCMS</method><comment /></metabolite><metabolite><id>2101</id><name>2-Oxoglutaric acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>79.00</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method>GCMS</method><comment /></metabolite><metabolite><id>2102</id><name>2-Oxoglutaric acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>79.00</max><unit>mmol/mol creatinine</unit><age>Adolescence</age><method>GCMS</method><comment /></metabolite><metabolite><id>329</id><name>2-Hydroxyglutaric acid (D)</name><specimen>urine</specimen><value>increased</value><min>3.00</min><max>17.00</max><unit>mmol/mol creatinine</unit><age>ALL</age><method>GCMS</method><comment /></metabolite><metabolite><id>2134</id><name>2-Hydroxyglutaric acid (D)</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>50.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>291</id><name>2-Hydroxyglutaric acid (D)</name><specimen>plasma</specimen><value>increased</value><min>0.30</min><max>0.90</max><unit>&#956;mol/l</unit><age>ALL</age><method>GCMS</method><comment /></metabolite><metabolite><id>328</id><name>2-Hydroxyglutaric acid (D)</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>0.07</min><max>0.30</max><unit>&#956;mol/l</unit><age>ALL</age><method>GCMS</method><comment /></metabolite><metabolite><id>1978</id><name>2-Oxoglutaric acid</name><specimen>urine</specimen><value>increased</value><min>160.00</min><max>590.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>1979</id><name>2-Oxoglutaric acid</name><specimen>urine</specimen><value>increased</value><min>2.00</min><max>17.00</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>163</id><name>4-Aminobutyric acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>not detectable</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1437</id><name>4-Aminobutyric acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>100.00</max><unit>nmol/l</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>162</id><name>4-Aminobutyric acid</name><specimen>plasma</specimen><value>increased</value><min>0.00</min><max>2.00</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>444</id><name>4-Aminobutyric acid</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>0.00</min><max>0.10</max><unit>&#956;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>541</id><name>Succinic acid</name><specimen>urine</specimen><value>increased</value><min>6.00</min><max>343.00</max><unit>mmol/mol creatinine</unit><age>infancy</age><method /><comment /></metabolite><metabolite><id>542</id><name>Succinic acid</name><specimen>urine</specimen><value>increased</value><min>4.00</min><max>27.00</max><unit>mmol/mol creatinine</unit><age>childhood 6-12y</age><method /><comment /></metabolite><metabolite><id>109</id><name>Succinic acid</name><specimen>urine</specimen><value>increased</value><min>5.30</min><max>46.30</max><unit>mmol/mol creatinine</unit><age>child</age><method /><comment /></metabolite><metabolite><id>356</id><name>Succinic acid</name><specimen>plasma</specimen><value>increased</value><min>0.00</min><max>32.00</max><unit>&#181;mol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>357</id><name>Succinic acid</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>0.00</min><max>5.00</max><unit>&#956;mol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>540</id><name>Succinic acid</name><specimen>urine</specimen><value>increased</value><min>29.40</min><max>486.20</max><unit>mmol/mol creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1488</id><name>Succinic acid</name><specimen>urine</specimen><value>increased</value><min>20.00</min><max>272.00</max><unit>mmol/mol creatinine</unit><age>newborn 1-7d</age><method /><comment /></metabolite><metabolite><id>1521</id><name>Succinic acid</name><specimen>urine</specimen><value>increased</value><min>40.00</min><max>125.00</max><unit>mmol/mol creatinine</unit><age>infancy</age><method /><comment /></metabolite><metabolite><id>1522</id><name>Succinic acid</name><specimen>urine</specimen><value>increased</value><min>5.00</min><max>81.00</max><unit>mmol/mol creatinine</unit><age>childhood</age><method /><comment /></metabolite><metabolite><id>1539</id><name>Succinic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>50.00</max><unit>mmol/mol creatinine</unit><age>ALL</age><method /><comment /></metabolite><metabolite><id>1688</id><name>Succinic acid</name><specimen>urine</specimen><value>increased</value><min>0.30</min><max>33.30</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite></Metabolites><Literatures><literature><id>6651</id><title>D-2-hydroxyglutaric aciduria type I: functional analysis of D2HGDH missense variants</title><author>Pop A,</author><journal>Hum Mutat</journal><year>2019</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>6974</id><title>D-2-hydroxyglutaric aciduria in a patient with speech delay due to a novel homozygous deletion in the D2HGDH gene</title><author>Phillips E,</author><journal>Mol Genet Metab Rep</journal><year>2019</year><book /><volume>20</volume><number>0</number><pages>100482</pages><co_aut>et al.</co_aut></literature><literature><id>3982</id><title>Experiences during newborn screening for glutaric aciduria type 1: Diagnosis, treatment, genotype, phenotype, and outcomes</title><author>Tsai FC,</author><journal>J Chin Med Assoc</journal><year>2017</year><book /><volume>80</volume><number>4</number><pages>253-261</pages><co_aut>et al.</co_aut></literature><literature><id>5214</id><title>Proposed recommendations for diagnosing and managing individuals with glutaric aciduria type I: second revision</title><author>Boy N,</author><journal>J Inherit Metab Dis</journal><year>2017</year><book /><volume>40</volume><number>1</number><pages>75-101</pages><co_aut>et al.</co_aut></literature><literature><id>3327</id><title>Combined D2-/L2-hydroxyglutaric aciduria (SLC25A1 deficiency): clinical course and effects of citrate treatment</title><author>Muehlhausen C,</author><journal>J Inherit Metab Dis</journal><year>2014</year><book /><volume>37</volume><number>5</number><pages>775-781</pages><co_aut>et al.</co_aut></literature><literature><id>3328</id><title>Novel cases of D-2-hydroxyglutaric aciduria with IDH1 or IDH2 mosaic mutations identified by amplicon deep sequencing</title><author>Nota B,</author><journal>J Med Genet</journal><year>2013</year><book /><volume>50</volume><number>11</number><pages>754-759</pages><co_aut>et al.</co_aut></literature><literature><id>3329</id><title>Deficiency in SLC25A1, encoding the mitochondrial citrate carrier, causes combined D-2- and L-2-hydroxyglutaric aciduria</title><author>Nota B,</author><journal>Am J Hum Genet</journal><year>2013</year><book /><volume>92</volume><number>4</number><pages>627-631</pages><co_aut>et al.</co_aut></literature><literature><id>3053</id><title>Progress in understanding 2-hydroxyglutaric acidurias</title><author>Martijn Kranendijk,</author><journal>J Inherit Metab Dis</journal><year>2012</year><book /><volume>35</volume><number>4</number><pages>571-587</pages><co_aut>et al.</co_aut></literature><literature><id>3983</id><title>Use of guidelines improves the neurological outcome in glutaric aciduria type I</title><author>Heringer J,</author><journal>Ann Neurol</journal><year>2010</year><book /><volume>68</volume><number>5</number><pages>743-752</pages><co_aut>et al.</co_aut></literature><literature><id>2809</id><title>Measurement of D: -2-hydroxyglutarate dehydrogenase activity in cell homogenates derived from D: -2-hydroxyglutaric aciduria pa</title><author>Wickenhagen WV,</author><journal>J Inherit Metab Dis</journal><year>2009</year><book /><volume>32</volume><number>2</number><pages>264-268</pages><co_aut>et al.</co_aut></literature><literature><id>2810</id><title>Peripheral neuropathy in a patient with D: -2-hydroxyglutaric aciduria</title><author>Haliloglu G,</author><journal>J Inher Metab Dis</journal><year>2009</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>2620</id><title>D-2-Hydroxyglutaric aciduria: unravelling the biochemical pathway and the genetic defect</title><author>Struys EA</author><journal>J Inher Met Dis</journal><year>2006</year><book /><volume>29</volume><number>0</number><pages>21-29</pages><co_aut /></literature><literature><id>1765</id><title>Metaphyseal enchondrodysplasia with 2-hydroxy-glutaric aciduria: observation of a third case and further delineation</title><author>Bayar A</author><journal>Clin Dysmorphol</journal><year>2005</year><book /><volume>14</volume><number>1</number><pages>7-11</pages><co_aut>et al.</co_aut></literature><literature><id>1875</id><title>Mutations in the D-2-hydroxyglutarate dehydrogenase gene cause D-2-hydroxyglutaric aciduria</title><author>Struys EA</author><journal>Am J Hum Genet</journal><year>2005</year><book /><volume>76</volume><number>2</number><pages>358-360</pages><co_aut>et al.</co_aut></literature><literature><id>2551</id><title>Mutations in phenotypically mild D-2-hydroxyglutaric aciduria</title><author>Struys EA</author><journal>Ann Neurol</journal><year>2005</year><book /><volume>58</volume><number>4</number><pages>626-630</pages><co_aut>et al.</co_aut></literature><literature><id>1344</id><title>Disease-related metabolites in culture medium of fibroblasts from patients with D-2-hydroxyglutaric aciduria, L-2-hydroxyglutar</title><author>Struys EA</author><journal>Clin Chem</journal><year>2003</year><book /><volume>49</volume><number>7</number><pages>1133-1138</pages><co_aut>et al.</co_aut></literature><literature><id>1345</id><title>D-2-Hydroxyglutaric aciduria with absence of corpus callosum and neonatal intracranial haemorrhage</title><author>Wang X</author><journal>J Inher Met Dis</journal><year>2003</year><book /><volume>26</volume><number>0</number><pages>92-94</pages><co_aut>Jakobs C, Bawle EV</co_aut></literature><literature><id>1346</id><title>D-2-Hydroxyglutaric aciduria in a patient with a severe clinical phenotype and unusual MRI findings</title><author>Wajne M</author><journal>J Inher Met Dis</journal><year>2002</year><book /><volume>25</volume><number>0</number><pages>28-34</pages><co_aut>et al.</co_aut></literature><literature><id>1516</id><title>Determination of the absolute configuration of 2-hydroxyglutaric acid and 5-oxoproline in urine samples by high-resolution NMR </title><author>Bal D</author><journal>J Pharm Biomed Anal</journal><year>2002</year><book /><volume>28</volume><number>6</number><pages>1061-1071</pages><co_aut>Gradowska W, Gryff-Keller A</co_aut></literature><literature><id>1347</id><title>Combined D-2- and L-2-hydroxyglutaric aciduria with neonatal onset encephalopathy: a third biochemical variant of 2-hydroxyglut</title><author>Muntau AC</author><journal>Neuropediatrics</journal><year>2000</year><book /><volume>31</volume><number>3</number><pages>137-140</pages><co_aut>et al.</co_aut></literature><literature><id>962</id><title>D-2-Hydroxyglutaric aciduria: evidence of clinical and biochemical heterogeneity</title><author>Wagner L</author><journal>J Inherit Metab Dis</journal><year>1998</year><book /><volume>21</volume><number>0</number><pages>247-250</pages><co_aut>Hoffmann GF, Jakobs C</co_aut></literature><literature><id>587</id><title>Persistent glycolic aciduria in a health child with normal alanine-glyoxylate aminotransferase activity</title><author>Craigen WJ</author><journal>J Inherit Metab Dis</journal><year>1996</year><book /><volume>19</volume><number>0</number><pages>793-794</pages><co_aut /></literature><literature><id>747</id><title>Various organic acidurias</title><author>Jakobs C</author><journal>in Blau N, Duran M, Blaskovics E (eds): in Physicians guuide to the laboratory diagnosis of metabolic diseases; Chapman and Hall, London</journal><year>1996</year><book /><volume>0</volume><number>0</number><pages>163-176</pages><co_aut>et al.</co_aut></literature><literature><id>1517</id><title>Chiral compounds as indicators of inherited metabolic disease. Simultaneous stereodifferentiation of lactic-, 2-hydroxyglutaric-</title><author>Kaunzinger A</author><journal>Enantiomer</journal><year>1996</year><book /><volume>1</volume><number>3</number><pages>177-182</pages><co_aut>et al.</co_aut></literature><literature><id>1518</id><title>2-Hydroxyglutaric aciduria: a case report on an infant with the D-isomeric form with review of the literature</title><author>Geerts Y</author><journal>J Neurol Sci</journal><year>1996</year><book /><volume>143</volume><number>0</number><pages>166-169</pages><co_aut>et al.</co_aut></literature><literature><id>44</id><title>D-2-Hydroxyglutaric acidemia: identification of a new enzyme, D-2-hydroxyglutarate dehydrogenase, localized in mitochondria</title><author>Wanders RJA</author><journal>J Inherit Metab Dis</journal><year>1995</year><book /><volume>18</volume><number>0</number><pages>196-196</pages><co_aut>Mooyer P</co_aut></literature><literature><id>751</id><title>Clinical and MRI findings in a case of D-2-hydroxyglutaric aciduria</title><author>Sugita K</author><journal>Brain Dev</journal><year>1995</year><book /><volume>17</volume><number>0</number><pages>139-141</pages><co_aut>et al.</co_aut></literature><literature><id>750</id><title>D-2-hydroxyglutaric aciduria</title><author>Nyhan WL</author><journal>J Child Neurol</journal><year>1994</year><book /><volume>10</volume><number>0</number><pages>137-142</pages><co_aut>et al.</co_aut></literature><literature><id>15</id><title>D-2-Hydroxyglutaric Aciduria in a Newborn with Neurological Abnormalities: A New Neurometabolic Disorder?</title><author>Gibson KM</author><journal>J Inherit Metab Dis</journal><year>1993</year><book /><volume>16</volume><number>0</number><pages>497-500</pages><co_aut>Craigen W, Herman GE, Jakobs C</co_aut></literature><literature><id>753</id><title>Stable isotope dilution analysis of D- and L-2-hydroxyglutaric acid: application to the detection and prenatal diagnosis od D- a</title><author>Gibson KM</author><journal>Pediatr Res</journal><year>1993</year><book /><volume>34</volume><number>0</number><pages>277-280</pages><co_aut>et al.</co_aut></literature><literature><id>748</id><title>D-2-hydroxyglutaric aciduria: case report and biochemical studies </title><author>Chalmers RA</author><journal>J Inherit Metab Dis</journal><year>1980</year><book /><volume>3</volume><number>0</number><pages>11-15</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>